主页 > 医学前沿 >
【medical-news】FDA更新三聚氰胺污染对健康的危害
The FDA had contacted the companies who manufacture infant formula for distribution in the United States and received information from the companies that they are not importing formula or source materials from China.
At the same time, the FDA—in conjunction with state and local officials—began a nation-wide investigation to check Asian markets for Chinese manufactured infant formula that may have been brought into the United States. In particular, this effort focused on areas of the country with large Chinese communities, such as Los Angeles, San Francisco, Seattle and New York. To date, investigators have visited more than 1,000 retail markets and have not found Chinese infant formula present on shelves in these markets.
In addition, the FDA is advising consumers not to purchase infant formula manufactured in China from internet sites or from other sources.
FDA has taken, and will continue to take, proactive measures to help ensure the safety of the American food supply. In conjunction with state and local officials, FDA will continue to check retail stores for food items imported from China that could contain a significant amount of milk or milk proteins. Additionally, FDA is sampling and testing milk and milk-derived ingredients and finished food products that could contain these ingredients from Chinese sources. Milk-derived ingredients include whole milk powder, non-fat milk powder, whey powder, lactose powder, and casein. This sampling and testing is done when these ingredients or products are imported into the United States or found during visits to Asian markets. If the products are adulterated because they contain melamine and/or a melamine analog, FDA will take action to prevent the products from entering the U.S. food supply.
In addition to state and local governments, FDA is working in close cooperation with Customs and Border Protection within the U.S. Department of Homeland Security, the U.S. Department of Agriculture, other federal agencies, and foreign governments.
http://www.mphtimes.com/us/index.php?option=com_content&view=article&id=813:fda-updates-health-information-advisory-on-melamine-contamination-&catid=34:public-health&Itemid=146 认领本文编译，48小时未交稿，其他战友可自由认领。
On September 12, 2008, in light of reports from China of melamine contaminated infant formula, the FDA issued a Health Information Advisory to proactively reassure the American public that there is no known threat of contamination in infant formula manufactured by companies that have met the requirements to sell such products in the United States. That advisory also warned members of Chinese communities in the United States that infant formula manufactured in China, possibly available for purchase at Asian markets, could pose a risk to infants.
2008年9月12日，根据来自中国的受三氯氰胺污染婴儿奶粉的报告，FDA发布了一份健康信息咨询报告以积极保证美国公众没有受到已知污染婴儿奶粉的威胁，生产企业也需要面对因需求的变化调整产品在国内的销售计划。这份咨询报告也警告在美国的中国社区，提供给亚洲市场的中国产婴儿奶粉可能对婴儿有危险。
The FDA had contacted the companies who manufacture infant formula for distribution in the United States and received information from the companies that they are not importing formula or source materials from China.
FDA联系了在美国生产和销售婴儿奶粉的企业，得到如下信息：他们没有从中国进口奶粉配方或原料。
At the same time, the FDA—in conjunction with state and local officials—began a nation-wide investigation to check Asian markets for Chinese manufactured infant formula that may have been brought into the United States. In particular, this effort focused on areas of the country with large Chinese communities, such as Los Angeles, San Francisco, Seattle and New York. To date, investigators have visited more than 1,000 retail markets and have not found Chinese infant formula present on shelves in these markets.
与此同时，FDA——连同国家和地方官员——开始一项全国范围的调查，以检查可能已经购入美国的、在亚洲市场销售的中国产婴儿奶粉。特别着重检查拥有大的华人社区的城市，比如洛杉矶、旧金山，西雅图和纽约。到目前为止，检查团已经访问了一千多家零售商店，发现这些商店的货架上并没有中国产婴儿奶粉。
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-06-02 05:11
医学,生命科学网